Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis

Cytokine

Volumn 33, Issue 3, 2006, Pages 171-178

  Nadif, Rachel ^a,b   Mintz, Margaret ^c   Rivas Fuentes, Selma ^a,d,f   Jedlicka, Anne ^c   Lavergne, Elise ^a,d   Rodero, Mathieu ^a,d   Kauffmann, Francine ^a,b   Combadière, Christophe ^a,d   Kleeberger, Steven R ^e  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d SORBONNE UNIVERSITÉ   (France)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

Chemokines; Interaction; Occupational exposure; Pneumoconiosis; Polymorphism

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN CX3CR1; RANTES; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; COAL WORKER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; PNEUMOCONIOSIS; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; CHEMOKINE CCL2; CHEMOKINES; CHEMOKINES, CC; COAL MINING; GENE FREQUENCY; GENOTYPE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; PHENOTYPE; PNEUMOCONIOSIS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 33644923223     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.01.001     Document Type: Article

References (48)

1. A.E.I. Proudfoot Chemokine receptors: multifaceted therapeutic targets Nat Rev Immunol 2 2002 106 115
2. C.A. Power Knock out models to dissect chemokine receptor function in vivo J Immunol Methods 273 2003 73 82
3. G. Gerard, and B.J. Rollins Chemokines and disease Nat Immunol 2 2001 108 115
4. R. McGinnis, F. Child, S. Clayton, S. Davies, W. Lenney, and T. Illig Further support for the association of CCR5 allelic variants with asthma susceptibility Eur J Immunogenet 29 2002 525 528
5. M. Petrek, J. Drabek, V. Kolek, J. Zlamal, I. Welsh, and M. Bunce CC Chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis Am J Respir Crit Care Med 162 2000 1000 1003
6. A.J. Sandford, S. Zhu, T.R. Bai, J.M. Fitzgerald, and P.D. Paré The role of the C-C chemokine receptor-5 Δ32 polymorphism in asthma and in the production of regulated on activation, normal T cells expressed and secreted J Allergy Clin Immunol 108 2001 69 73
7. P. Srivastava, P.J. Helms, D. Stewart, M. Main, and G. Russell Association of CCR5 Δ32 with reduced risk of childhood but not adult asthma Thorax 58 2003 222 226
8. N. Hizawa, E. Yamaguchi, K. Furuya, E. Jinushi, A. Ito, and Y. Kawakami The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population Am J Respir Crit Care Med 159 1999 2021 2023
9. R.G. Nickel, V. Casolaro, U. Wahn, K. Beyer, K.C. Barnes, and B.S. Plunkett Atopic dermatitis is associated with a functional mutation in the promoter of the C-C Chemokine RANTES J Immunol 164 2000 1612 1616
10. A.A. Fryer, M.A. Spiteri, A. Bianco, M. Hepple, P.W. Jones, and R.C. Strange The -403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma Genes Immun 1 2000 509 514
11. T. Takada, E. Suzuki, T. Ishida, H. Moriyama, H. Ooi, and T. Hasegawa Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in a Japanese population Tissue Antigens 58 2001 293 298
12. M.H. Dizier, C. Besse-Schmittler, M. Guilloud-Bataille, I. Annesi-Maesano, M. Boussaha, and J. Bousquet Genome screen for asthma and related phenotypes in the French EGEA study Am J Respir Crit Care Med 162 2000 1812 1818
13. S.A. Al-Abdulhadi, P.J. Helms, M. Main, O. Smith, and G. Christie Preferential transmission and association of the -403 G→A promoter RANTES polymorphism with atopic asthma Genes Immun 6 2005 24 30
14. N. Hizawa, E. Yamaguchi, S. Konno, Y. Tanino, E. Jinushi, and M. Nishimura A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma Am J Respir Crit Care Med 166 2002 686 690
15. T.C. Yao, M.L. Kuo, L.C. See, L.C. Chen, D.C. Yan, and L.S. Ou The RANTES promoter polymorphism: a genetic risk factor for near-fatal asthma in Chinese children J Allergy Clin Immunol 111 2003 1285 1292
16. B.H. Rovin, L. Lu, and R. Saxena A novel polymorphism in the MCP-1 gene regulatory region that influence MCP-1 expression Biochem Biophys Res Commun 259 1999 344 348
17. C. Szalai, G.T. Kozma, A. Nagy, A. Bojszko, D. Krikovszky, and T. Szabo Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity J Allergy Clin Immunol 108 2001 375 381
18. T.C. Yao, K.C. Wu, H.T. Chung, C.K. Shaw, M.L. Kuo, and C.J. Wu MCP-1 gene regulatory region polymorphism in Chinese children with mild, moderate and near-fatal asthma Allergy 59 2004 436 441
19. C. Laprise, R. Sladek, A. Ponton, M.C. Bernier, T.J. Hudson, and M. Laviolette Functional classes of bronchial mucosa genes that are differentially expressed in asthma BMC Genomics 5 2004 21 30
20. M. Daoudi, E. Lavergne, A. Garin, N. Tarantino, P. Debre, and F. Pincet Enhanced adhesive capacities of the naturally occurring Ile249-Met280 variant of the chemokine receptor CX3CR1 J Biol Chem 279 2004 19649 19657
21. D. D'Ambrosio, M. Mariani, P. Panina-Bordignon, and F. Sinigaglia Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation Am J Respir Crit Care Med 164 2001 1266 1275
22. H.Y. Reynolds Lung inflammation and fibrosis: an alveolar macrophage-centered perspective from the 1970s to 1980s Am J Respir Crit Care Med 171 2005 98 102
23. M. Gharaee-Kermani, R.E. McCullumsmith, I.F. Charo, S.L. Kunkel, and S.H. Phan CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis Cytokine 24 2003 266 276
24. Y. Zhou, T. Kurihara, R.P. Ryseck, Y. Yang, C. Ryan, and J. Loy Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor J Immunol 160 1998 4018 4025
25. J.W. Tyner, O. Uchida, N. Kajiwara, E.Y. Kim, A.C. Patel, and M.P. O'Sullivan CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection Nat Med 11 2005 1180 1187
26. A. Capelli, A. Di Stefano, M. Lusuardi, I. Gnemmi, and C.F. Donner Increased macrophage inflammatory protein-1alpha and macrophage inflammatory protein-1beta levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis Am J Respir Crit Care Med 165 2002 236 241
27. M. Hasegawa, S. Sato, T. Echigo, Y. Hamaguchi, M. Yasui, and K. Takehara Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis Ann Rheum Dis 64 2005 21 28
28. M. Rémy-Jardin, J. Rémy, I. Farre, and C.H. Marquette Computed tomographic evaluation of silicosis and coal workers' pneumoconiosis Radiol Clin North Am 30 1992 1155 1176
29. A. Savranlar, R. Altin, K. Mahmutyazicioglu, H. Ozdemir, L. Kart, and T. Ozer Comparison of chest radiography and high-resolution computed tomography findings in early and low-grade coal worker's pneumoconiosis Eur J Radiol 51 2004 175 180
30. E. Bourgkard, P. Bernadac, N. Chau, J.P. Bertrand, D. Teculescu, and Q.T. Pham Can the evolution to pneumoconiosis be suspected in coal miners? A longitudinal study Am J Respir Crit Care Med 158 1998 504 509
31. R. Nadif, A. Jedlicka, M. Mintz, J.P. Bertrand, S. Kleeberger, and F. Kauffmann Effect of TNF and LTA polymorphisms on biological markers of response to oxidative stimuli in coal miners: a model of gene-environment interaction J Med Genet 40 2003 96 103
32. M.D. Attfield, and K. Morring The derivation of estimated dust exposures for U.S. coal miners working before 1970 Am Ind Hyg Assoc J 53 1992 248 255
33. ++ superoxide dismutase activities, and the severity of coal worker's pneumoconiosis Occup Environ Med 55 1998 533 540
34. International Labour Office (ILO) Guideline for the use of ILO international classification of radiographs of pneumoconiosis 1980 ILO division of Occupational Safety and Health Sciences Geneva publication 22
35. E. Lavergne, J. Labreuche, M. Daoudi, P. Debre, F. Cambien, and P. Deterre Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease Arterioscler Thromb Vasc Biol 25 2005 847 853
36. D.A. Tregouet, S. Barbaux, O. Poirier, S. Blankenberg, C. Bickel, and S. Escolano SELPLG gene polymorphisms in relation to plasma SELPLG levels and coronary artery disease Ann Hum Genet 67 2003 504 511
37. J.P. Bayley, J.M. Baggen, T. van der Pouw-Kraan, J.B. Crusius, T.W. Huizinga, and C.L. Verweij Association between polymorphisms in the human chemokine receptor genes CCR2 and CX3CR1 and rheumatoid arthritis Tissue Antigens 62 2003 170 174
38. A. Gugl, W. Renner, G. Seinost, M. Brodmann, E. Pabst, and T.C. Wascher Two polymorphisms in the fractalkine receptor CX3CR1 are not associated with peripheral arterial disease Atherosclerosis 166 2003 339 343
39. P. Spagnolo, E.A. Renzoni, A.U. Wells, S.J. Copley, S.R. Desai, and H. Sato C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis Am J Respir Crit Care Med 172 2005 721 728
40. N.R. Landau Recent advances in AIDS research: genetics, molecular biology and immmunology Curr Opin Immunol 11 1999 449 450
41. R. Valentonyte, J. Hampe, P.J. Croucher, J. Muller-Quernheim, E. Schwinger, and S. Schreiber Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family based analysis Am J Respir Crit Care Med 171 2005 1136 1141
42. T.C. Dawson, M.A. Beck, W.A. Kuziel, F. Henderson, and N. Maeda Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus Am J Pathol 156 2000 1951 1959
43. M.P. Quinones, S.K. Ahuja, F. Jimenez, J. Schaefer, E. Garavito, and A. Rao Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis J Clin Invest 113 2004 856 866
44. A.M. Ferreira, B.J. Rollins, D.E. Faunce, A.L. Burns, X. Zhu, and L.A. Dipietro The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation Cytokine 30 2005 64 71
45. + individuals with a structural variant of the chemokine receptor CX3CR1 Science 287 2000 2274 2277
46. D.H. McDermott, A.M. Fong, Q. Yang, J.M. Sechler, L.A. Cupples, and M.N. Merrell Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans J Clin Invest 111 2003 1241 1250
47. D. Moatti, S. Faure, F. Fumeron, Mel-W. Amara, P. Seknadji, and D.H. McDermott Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease Blood 97 2001 1925 1928
48. A.C. Rimaniol, S.J. Till, G. Garcia, F. Capel, V. Godot, and K. Balabanian The CX3C chemokine fractalkine in allergic asthma and rhinitis J Allergy Clin Immunol 112 2003 1139 1146